Life Insurance Corporation’s portfolio gains Rs 28,97,48,995 in just 1 day from this multibagger stock; Hits all-time high & trades at triple-digit PE
DSIJ Intelligence-1 / 09 Jul 2025/ Categories: Multibaggers, Trending
The stock is trading at a triple-digit PE of 140x whereas the industry PE is 33x with an ROE of 7.5 per cent and an ROCE of 9 per cent.
On Wednesday, the stock market was trading flat with the Sensex up 0.06 per cent and Nifty-50 up 0.03 per cent. Along with the market in green, one multibagger stock from the Healthcare sector jumped 2.55 per cent and made an all-time high and a 52-week high of Rs 797.90 per share from its previous closing of Rs 778 per share. The stock is up by 45 per cent in just 3 months and has given multibagger returns of 600 per cent in 5 years.
In just 1 day, Life Insurance Corporation’s portfolio gains Rs 28,97,48,995 from this stock (1,45,60,251 shares x 19.9 per share). Additionally, an ace investor, Akash Bhanshali, owns a 1.33 per cent stake in the company as of March 2025.
The stock name is Laurus Labs Ltd.
Laurus Labs Ltd., established in 2005, is a research-focused pharmaceutical and biotechnology company that has achieved global leadership in specific Active Pharmaceutical Ingredients (APIs). Their expertise extends to anti-retroviral and oncology drugs, including high-potency APIs, as well as cardiovascular and gastrotherapeutics. The company also provides comprehensive Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) services to global innovators, spanning from clinical phase drug development to commercial manufacturing. Laurus Labs employs over 6,500 individuals, including more than 1,050 scientists and operates at over 11 facilities that have received approvals from various global regulatory bodies such as the USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA and TGA.
DSIJ offers a service 'PAS' which provides stock recommendations that have the potential to generate excellent returns on your portfolio. If this interests you, then do download the service details pdf here
In FY25, the company did net sales of Rs 5,554 crore and net profit of Rs 358 crore. The company has a market cap of over Rs 40,000 crore and has been maintaining a healthy dividend payout of 19.5 per cent. The stock is trading at a triple-digit PE of 140x whereas the industry PE is 33x with an ROE of 7.5 per cent and an ROCE of 9 per cent.
Disclaimer: The article is for informational purposes only and not investment advice.